PDK4 antisense RNA 1 (PDK4-AS1)

PDK4 antisense RNA 1 (PDK4-AS1) is a long non-coding RNA (lncRNA) transcript transcribed antisense to the pyruvate dehydrogenase kinase 4 (PDK4) gene[1]. Unlike classical therapeutic targets such as protein-coding genes or receptors, PDK4-AS1 does not code for a protein but is thought to function at the RNA level, potentially by regulating the expression or stability of PDK4 mRNA through RNA-RNA or RNA-protein interactions[1]. Recent research indicates that PDK4-AS1 acts as a competing endogenous RNA (ceRNA) for miR-107, thereby modulating PDK4 expression and influencing ovarian cancer cell proliferation, migration, and invasion[2]. There is currently no evidence that PDK4-AS1 itself is a direct or actionable therapeutic target by traditional means, and it is not associated with any known drugs or direct safety concerns. Key clarification: Although PDK4 is a well-established metabolic enzyme and therapeutic target candidate in various diseases, PDK4-AS1 (PDK4 antisense RNA 1) is not itself a therapeutic target but rather a regulatory non-coding RNA implicated in gene expression modulation[1][2]. Thus, this entry is marked as "is_target: false" and "is_incorrect: true" for therapeutic target purposes.

Other names

PDK4 antisense RNA 1PDK4-AS1

Not applicable (not a protein/gene product typically targeted by drugs; functions via ceRNA or antisense mechanisms)